Granules India secures USFDA approval for antidepressant tablets

Bupropion hydrochloride extended-release tablets are widely prescribed for the treatment of major depressive disorder and for the prevention of seasonal affective disorder.

Bupropion hydrochloride extended-release tablets are widely prescribed for the treatment of major depressive disorder and for the prevention of seasonal affective disorder.

Post Content

Crown Holdings, a global leader in packaging, reported a 5% growth in global beverage can shipments during the past quarter, with strong performance in key markets such as Brazil, Mexico, Europe, and the USA. This robust growth bodes well for…

In terms of deposits, Axis Bank reported a 14% YOY increase, with term deposits soaring by 21% YOY. Current Account Savings Account (CASA) deposits saw a more modest growth of 4% YOY.

Indraprastha Gas said that it is in discussion with key stakeholders to minimise the impact.

The Sensex fell 495 points to settle at 81,007, while the Nifty dropped 221 points to 24,751.

Anurag Singh, Managing Partner of Ansid Capital believes that the Indian market is due for a “time correction,” which would be beneficial for long-term investors, particularly those investing through systematic investment plans (SIPs).

Additionally, Shriram Finance said its board will declare an interim dividend for the financial year 2024-25. Record date for the said interim dividend has been fixed as November 7, 2024.

Godavari Biorefineries will have a post-listing market capitalisation of ₹1,801 crore at the upper end of the price band.

Ajmera will seek shareholder approval for the same at its Extra-ordinary General Meeting (EGM) on November 14, 2024.